| 50.22 0.27 (0.54%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 61.36 | 1-year : | 71.67 |
| Resists | First : | 52.54 | Second : | 61.36 |
| Pivot price | 49.76  |
|||
| Supports | First : | 49.04 |
Second : | 46.88 |
| MAs | MA(5) : | 50.89 |
MA(20) : | 49.56 |
| MA(100) : | 52.56  |
MA(250) : | 59.36 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 68.5 |
D(3) : | 76.8 |
| RSI | RSI(14): 53.1 |
|||
| 52-week | High : | 75.3 | Low : | 42.61 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PBH ] has closed below upper band by 40.7%. Bollinger Bands are 31.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 50.53 - 50.73 | 50.73 - 50.9 |
| Low: | 48.52 - 48.76 | 48.76 - 48.98 |
| Close: | 49.79 - 50.2 | 50.2 - 50.54 |
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
Fri, 31 Jul 2026
Price to sales forward of Prestige Consumer Healthcare Inc. – NYSE:PBH - TradingView
Fri, 31 Jul 2026
Prestige Consumer Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Fri, 31 Jul 2026
PBH|Prestige Consumer Healthcare Inc|Price:49.910|Chg%:-2.280 - TradingKey
Thu, 30 Jul 2026
PBH|Prestige Consumer Healthcare Inc|Price:52.180|Chg%:+0.460 - TradingKey
Sat, 04 Jul 2026
Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition - Yahoo Finance
Mon, 29 Jun 2026
Prestige Consumer Healthcare Inc. ($PBH) Chair, President, and CEO 2026 Pay Revealed - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 0 (M) |
| Shares Float | 47 (M) |
| Held by Insiders | 1.3 (%) |
| Held by Institutions | 113.8 (%) |
| Shares Short | 3,090 (K) |
| Shares Short P.Month | 2,930 (K) |
| EPS | 3.91 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 17.4 % |
| Operating Margin | 26.8 % |
| Return on Assets (ttm) | 5.6 % |
| Return on Equity (ttm) | 10.2 % |
| Qtrly Rev. Growth | -5 % |
| Gross Profit (p.s.) | 12.79 |
| Sales Per Share | 23.01 |
| EBITDA (p.s.) | 7.19 |
| Qtrly Earnings Growth | 12.3 % |
| Operating Cash Flow | 258 (M) |
| Levered Free Cash Flow | 193 (M) |
| PE Ratio | 12.84 |
| PEG Ratio | 1.4 |
| Price to Book value | 0 |
| Price to Sales | 2.18 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|